2019
DOI: 10.1016/j.bioorg.2018.11.047
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 8-hydroxyquinoline glycoconjugates and preliminary assay of their β1,4-GalT inhibitory and anti-cancer properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
38
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 39 publications
(39 citation statements)
references
References 81 publications
1
38
0
Order By: Relevance
“…We have recently shown that the 1,2,3-triazole ring is an important element for glycoconjugate activity [54] (Figure 1). Except for the role of a connection between two active groups, it also has other interesting properties.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have recently shown that the 1,2,3-triazole ring is an important element for glycoconjugate activity [54] (Figure 1). Except for the role of a connection between two active groups, it also has other interesting properties.…”
Section: Introductionmentioning
confidence: 99%
“…The general structure of the planned glycoconjugates is shown in Figure 2. It was decided to reverse the direction of linking reactive moieties compared to the previously reported glycoconjugates [54], consisting of sugar azides and propargyl derivatives of 8-HQ (Figure 1) and see how this will affect the activity of glycoconjugates. In addition, it was decided to check how the structure modification of the linker of the quinoline glycoconjugates affects their biological properties.…”
Section: Introductionmentioning
confidence: 99%
“…A new series of glycoconjugates composed of various sugar units ( 40 , 41 ) ( d -glucose or d -galactose) and 8-hydroxyquinolines ( 42 , 43 ) was prepared in an effective and simple method [ 29 ]. The connection between these units was accomplished by O -glycosidic bond or via O -methylene 1,2,3-triazole linker, as shown in Scheme 11 .…”
Section: Anticancer Activitymentioning
confidence: 99%
“…Qiu et al proved that NF-κB inhibitor BAY11-7082 blocks NF-κB transcription, and ER-mediated induction of cell proliferation upon its activity was reversed [21]. These data are useful in the development of therapy strategies for IBC, with ER-positive breast tumors usually resistant to endocrine therapy [24,25,26]. In the line with this evidence, the search for new potential inhibitors of NF-κB is necessary.…”
Section: Discussionmentioning
confidence: 99%